Steris (NYSE: STE) reported Q3 EPS of $0.98, $0.06 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $646.8 million versus the consensus estimate of $679.14 million.

GUIDANCE:

Steris sees FY2017 EPS of $3.70-$3.76, versus the consensus of $3.89.

For earnings history and earnings-related data on Steris (STE) click here.